Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Validation of a novel web-based application for hepatic arterial infusion floxuridine dosing.
Authors
Carleton Scott Ellis
Department of Pharmacy, University of Kentucky HealthCare, Lexington, KY
Carleton Scott Ellis , Snigdha Nutalapati , Jessica Jane Moss , Mautin S. Barry-Hundeyin , Prakash Pandalai , Joseph Kim , Reema Anil Patel , Michael J. Cavnar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Cancer Disparities
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 15)
DOI
10.1200/JCO.2024.42.3_suppl.15
Abstract #
15
Poster Bd #
B16
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Experiences of patients with bladder cancer: A comparison of urban and rural areas.
First Author: Lydia Makaroff
Poster
2023 ASCO Quality Care Symposium
Virtual easy-to-access hematology tumor boards: Scaling disease expertise across multiple sites of care across urban and rural Tennessee.
First Author: Christy L. Schneider
Poster
2023 ASCO Quality Care Symposium
Geographic accessibility to palliative care clinicians for patients with newly diagnosed stage 4 cancer in the United States.
First Author: Changchuan Jiang
Poster
2023 ASCO Annual Meeting
Adjuvant systemic chemotherapy with or without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastases resection (HARVEST): A prospective, randomized controlled trial.
First Author: Yu-hong Li